Du Shao-Bing, Zhou Hui-Hui, Wang Peng-Fei, Wang Xiao-Ping, Xue Zhi-Peng, Li Jing, Gao Su, Li Na, Bai Ji-Qing, Xie Li-Hong
College of pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
FEMS Microbiol Lett. 2022 Apr 21;369(1). doi: 10.1093/femsle/fnac036.
In the recent years, a growing number of studies have shown that the occurrence of myocardial ischemia (MI) is closely related to the gut microbiota (GM). The Danshen-Honghua herb pair (DHHP), a classic combination in traditional Chinese herbal formulas, has been widely applied throughout history to cure cardiovascular disease, exhibiting remarkable clinical efficacy to treat ischemic heart disease (IHD). However, the intrinsic regulation mechanism of DHHP in treating MI remains unclear. This study aims to investigate the possible protective mechanism of DHHP in rats with acute myocardial ischemia (AMI) induced by isoproterenol (ISO) through 16S rRNA gene sequencing technique. Pharmacodynamic results showed that DHHP significantly ameliorated the pathological changes and improved the abnormal cardiac enzymes levels in the AMI rats. In addition, GM analysis demonstrated that DHHP effectively ameliorated the ISO-induced dysbiosis of the GM community, mainly by enhancing the GM diversity and increasing the relative abundance of Bacteroides, Roseburia, unclassified_f__Lachnospiraceae, and Lachnospiraceae_NK4A136_group, the abundance ratio of Bacteroidetes to Firmicutes, and decreasing the relative abundance of Escherichia-Shigella and Enterococcus. In summary, this study revealed that DHHP could improve ischemic myocardial injury in rats, and that its regulation mechanism is associated with significantly ameliorating the composition of GM, thus contributing to further our understanding of the anti-MI mechanisms of DHHP.
近年来,越来越多的研究表明,心肌缺血(MI)的发生与肠道微生物群(GM)密切相关。丹参-红花药对(DHHP)是中药方剂中的经典组合,历史上已被广泛应用于治疗心血管疾病,在治疗缺血性心脏病(IHD)方面显示出显著的临床疗效。然而,DHHP治疗MI的内在调节机制仍不清楚。本研究旨在通过16S rRNA基因测序技术探讨DHHP对异丙肾上腺素(ISO)诱导的急性心肌缺血(AMI)大鼠的可能保护机制。药效学结果表明,DHHP显著改善了AMI大鼠的病理变化,降低了异常心肌酶水平。此外,GM分析表明,DHHP有效地改善了ISO诱导的GM群落失调,主要是通过提高GM多样性、增加拟杆菌属、罗斯氏菌属、未分类的毛螺菌科和毛螺菌科NK4A136组的相对丰度、拟杆菌门与厚壁菌门的丰度比,以及降低大肠杆菌-志贺氏菌属和肠球菌的相对丰度。总之,本研究表明,DHHP可以改善大鼠缺血性心肌损伤,其调节机制与显著改善GM组成有关,从而有助于进一步了解DHHP的抗MI机制。